1. 65P Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: A large real life worldwide population. (December 2022) Authors: Rimini, M.; Casadei Gardini, A.; Persano, M.; Suda, G.; Tada, T.; Shimose, S.; Kudo, M.; Cheon, J.; Finkelmeier, F.; Rimassa, L.; Presa, J.; Masi, G.; Yoo, C.; Lonardi, S.; Tovoli, F.; Piscaglia, F.; Iavarone, M.A.; Scartozzi, M.; Burgio, V.; Cascinu, S. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 67P Real-world data for atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. (December 2022) Authors: Persano, M.; Rimini, M.; Tada, T.; Suda, G.; Shimose, S.; Kudo, M.; Cheon, J.; Finkelmeier, F.; Rimassa, L.; Presa, J.; Masi, G.; Yoo, C.; Lonardi, S.; Piscaglia, F.; Burgio, V.; Scartozzi, M.; Cascinu, S.; Casadei Gardini, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Commentary: vitamin D deficiency and liver cancer – cause, effect or myth? Authors' reply. Issue 12 (June 2014) Authors: Finkelmeier, F.; Kronenberger, B.; Köberle, V.; Bojunga, J.; Zeuzem, S.; Trojan, J.; Piiper, A.; Waidmann, O. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 12(2014) Page Start: 1429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection. Issue 11 (10th April 2018) Authors: Kuhnhenn, L.; Jiang, B.; Kubesch, A.; Vermehren, J.; Knop, V.; Susser, S.; Dietz, J.; Carra, G.; Finkelmeier, F.; Grammatikos, G.; Zeuzem, S.; Sarrazin, C.; Hildt, E.; Peiffer, K.‐H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 11(2018) Page Start: 1523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study. Issue 10 (29th March 2014) Authors: Finkelmeier, F.; Kronenberger, B.; Köberle, V.; Bojunga, J.; Zeuzem, S.; Trojan, J.; Piiper, A.; Waidmann, O. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 10(2014) Page Start: 1204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗